Zevalin and Aspergillosis - a phase IV clinical study of FDA data

Summary:

Aspergillosis is reported as a side effect among people who take Zevalin (ibritumomab tiuxetan), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Fludarabine Phosphate, and have Burkitt lymphoma.

The phase IV clinical study analyzes which people have Aspergillosis when taking Zevalin. It is created by eHealthMe based on reports of 2,256 people who have side effects when taking Zevalin from the FDA, and is updated regularly.

What is Zevalin?

Zevalin has active ingredients of ibritumomab tiuxetan. eHealthMe is studying from 2,258 Zevalin users. Check the latest studies of Zevalin.

What is Aspergillosis?

Aspergillosis (an infection caused by a fungus called aspergillus) is found to be associated with 234 drugs and 531 conditions by eHealthMe. Check the latest studies of Aspergillosis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 29, 2026

2,256 people reported to have side effects when taking Zevalin.
Among them, 15 people (0.66%) have Aspergillosis.

Among these 15 people:

How long have people been on Zevalin when they have Aspergillosis? *

What is the gender of people who have Aspergillosis when taking Zevalin? *

female: 8.33 %
male: 91.67 %

What is the age of people who have Aspergillosis when taking Zevalin? *

What are other drugs people take besides Zevalin? *

Fludarabine Phosphate: 10 people, 66.67%
Melphalan: 9 people, 60.00%
Cyclosporine: 7 people, 46.67%
Ambisome: 7 people, 46.67%
Budesonide: 6 people, 40.00%
Neupogen: 6 people, 40.00%
Omeprazole: 6 people, 40.00%
Ganciclovir: 6 people, 40.00%
Tacrolimus: 6 people, 40.00%
Piperacillin And Tazobactam: 5 people, 33.33%

What are other side effects people have besides Aspergillosis? *

Multi-Organ Failure (multisystem organ failure): 8 people, 53.33%
Cytomegalovirus Colitis (an inflammation of the colon from virus): 6 people, 40.00%
Septic Shock (shock due to blood infection): 6 people, 40.00%
Sepsis (a severe blood infection that can lead to organ failure and death): 6 people, 40.00%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 5 people, 33.33%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 4 people, 26.67%
Diarrhea: 4 people, 26.67%
Pneumonia: 3 people, 20.00%
Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 3 people, 20.00%
Thrombocytopenia (decrease of platelets in blood): 2 people, 13.33%

What are the existing conditions these people have? *

Burkitt Lymphoma (cancer of the lymphatic system): 6 people, 40.00%
Sepsis (a severe blood infection that can lead to organ failure and death): 4 people, 26.67%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 4 people, 26.67%
Cytomegalovirus Colitis (an inflammation of the colon from virus): 4 people, 26.67%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 4 people, 26.67%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 3 people, 20.00%
Cholestasis (a condition where bile cannot flow from the liver to the duodenum): 2 people, 13.33%
Bone Marrow Conditioning Regimen: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Zevalin and have Aspergillosis?

- Check whether Aspergillosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zevalin:

Zevalin (2,258 reports)

Aspergillosis treatments and more:

Aspergillosis (4,156 reports)

Browse all side effects of Zevalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Aspergillosis:

Aspergillosis (234 drugs)

Browse all the conditions that are associated with Aspergillosis:

Aspergillosis (531 conditions)

Related publications that referenced our studies

Biswal S, "Complete heart block in a neutropenic patient with aspergillosis: An unusual adverse effect of caspofungins", Journal of pharmacology & pharmacotherapeutics, 2012 Jan .
Biswal S, "Complete heart block in a neutropenic patient with aspergillosis: An unusual adverse effect of caspofungins", Journal of pharmacology & pharmacotherapeutics, 2012 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on ibritumomab tiuxetan (the active ingredients of Zevalin) and Zevalin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.